-In collaboration with Monash R&D, we registered four provisional patents based on our innovative CNN architecture and hardware designs.
-Kāhu received $3M in funding from Pioneer Capital and Precision Driven Health to launch our first A.I. products
-Leading skin cancer researchers at Monash University published a protocol in British Medical Journal for the SMARTi trial which utilised our A.I.
-Our first decision-support product was released - Kāhu GP Assist - helping doctors to identify and diagnose faster and more efficiently.
-Kāhu's Priority Care product was launched, helping TeleHealth companies prioritize at-risk patients.